PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
QLD vs. CURE
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Key characteristics


QLDCURE
YTD Return35.76%0.81%
1Y Return52.09%20.00%
3Y Return (Ann)5.12%-5.03%
5Y Return (Ann)30.32%10.92%
10Y Return (Ann)28.55%13.08%
Sharpe Ratio1.500.67
Sortino Ratio1.991.08
Omega Ratio1.271.14
Calmar Ratio1.960.53
Martin Ratio6.522.55
Ulcer Index8.03%8.46%
Daily Std Dev34.85%32.07%
Max Drawdown-83.13%-69.19%
Current Drawdown-6.92%-28.66%

Correlation

-0.50.00.51.00.6

The correlation between QLD and CURE is 0.64, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.

Performance

QLD vs. CURE - Performance Comparison

In the year-to-date period, QLD achieves a 35.76% return, which is significantly higher than CURE's 0.81% return. Over the past 10 years, QLD has outperformed CURE with an annualized return of 28.55%, while CURE has yielded a comparatively lower 13.08% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


2,000.00%2,500.00%3,000.00%3,500.00%4,000.00%4,500.00%JuneJulyAugustSeptemberOctoberNovember
4,139.42%
2,138.35%
QLD
CURE

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


QLD vs. CURE - Expense Ratio Comparison

QLD has a 0.95% expense ratio, which is lower than CURE's 1.08% expense ratio.


CURE
Direxion Daily Healthcare Bull 3x Shares
Expense ratio chart for CURE: current value at 1.08% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%1.08%
Expense ratio chart for QLD: current value at 0.95% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.95%

Risk-Adjusted Performance

QLD vs. CURE - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for ProShares Ultra QQQ (QLD) and Direxion Daily Healthcare Bull 3x Shares (CURE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


QLD
Sharpe ratio
The chart of Sharpe ratio for QLD, currently valued at 1.50, compared to the broader market0.002.004.006.001.50
Sortino ratio
The chart of Sortino ratio for QLD, currently valued at 1.99, compared to the broader market-2.000.002.004.006.008.0010.0012.001.99
Omega ratio
The chart of Omega ratio for QLD, currently valued at 1.27, compared to the broader market0.501.001.502.002.503.001.27
Calmar ratio
The chart of Calmar ratio for QLD, currently valued at 1.96, compared to the broader market0.005.0010.0015.001.96
Martin ratio
The chart of Martin ratio for QLD, currently valued at 6.52, compared to the broader market0.0020.0040.0060.0080.00100.00120.006.52
CURE
Sharpe ratio
The chart of Sharpe ratio for CURE, currently valued at 0.67, compared to the broader market0.002.004.006.000.67
Sortino ratio
The chart of Sortino ratio for CURE, currently valued at 1.08, compared to the broader market-2.000.002.004.006.008.0010.0012.001.08
Omega ratio
The chart of Omega ratio for CURE, currently valued at 1.14, compared to the broader market0.501.001.502.002.503.001.14
Calmar ratio
The chart of Calmar ratio for CURE, currently valued at 0.53, compared to the broader market0.005.0010.0015.000.53
Martin ratio
The chart of Martin ratio for CURE, currently valued at 2.55, compared to the broader market0.0020.0040.0060.0080.00100.00120.002.55

QLD vs. CURE - Sharpe Ratio Comparison

The current QLD Sharpe Ratio is 1.50, which is higher than the CURE Sharpe Ratio of 0.67. The chart below compares the historical Sharpe Ratios of QLD and CURE, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.501.001.502.002.50JuneJulyAugustSeptemberOctoberNovember
1.50
0.67
QLD
CURE

Dividends

QLD vs. CURE - Dividend Comparison

QLD's dividend yield for the trailing twelve months is around 0.28%, less than CURE's 1.51% yield.


TTM20232022202120202019201820172016201520142013
QLD
ProShares Ultra QQQ
0.28%0.33%0.31%0.00%0.00%0.13%0.06%0.02%0.90%0.11%0.19%0.13%
CURE
Direxion Daily Healthcare Bull 3x Shares
1.51%2.02%0.38%0.02%0.17%0.40%0.70%0.18%0.00%0.00%0.00%1.24%

Drawdowns

QLD vs. CURE - Drawdown Comparison

The maximum QLD drawdown since its inception was -83.13%, which is greater than CURE's maximum drawdown of -69.19%. Use the drawdown chart below to compare losses from any high point for QLD and CURE. For additional features, visit the drawdowns tool.


-30.00%-25.00%-20.00%-15.00%-10.00%-5.00%0.00%JuneJulyAugustSeptemberOctoberNovember
-6.92%
-28.66%
QLD
CURE

Volatility

QLD vs. CURE - Volatility Comparison

ProShares Ultra QQQ (QLD) has a higher volatility of 11.27% compared to Direxion Daily Healthcare Bull 3x Shares (CURE) at 10.51%. This indicates that QLD's price experiences larger fluctuations and is considered to be riskier than CURE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


4.00%6.00%8.00%10.00%12.00%14.00%16.00%18.00%JuneJulyAugustSeptemberOctoberNovember
11.27%
10.51%
QLD
CURE